EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 2.5

Management of Agitation in Dementia and Effects on Inpatient Length of Stay

Isabelle Silverstone-Simard, Joyce Wu, Marouane Nassim, Ruby Friedman, Marilyn Segal, Johanne Monette, Soham Rej

Canadian Geriatrics Journal · 11.05.2021 · 24 (2) · 111-117

DOI: 10.5770/cgj.24.483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Geriatrics Journal, online erschienen am 11.05.2021. Verfasst von Isabelle Silverstone-Simard und 6 weiteren Autor:innen. Beteiligte Einrichtung: GeriPARTy Research Group, Dept. of Psychiatry, Lady Davis Institute/Jewish General Hospital, McGill University, Montreal, QC. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 2.5).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Agitation associated with dementia impacts delivery of medical care and is a major reason for institutionalization in dementia patients. This study examines the association of medication use and other clinical factors with patients’ ‘dischargeability’ (i.e., amount of time until a patient is considered dischargeable from an inpatient unit).

Methods

This study was a retrospective chart review examining 200 patients with dementia and agitation, hospitalized at a Canadian acute care geriatric ward between November 2007 and November 2018. The main outcome measure was time until a patient was deemed dischargeable. Univariate linear regression analyses, followed by multiple linear regression analyses, were used.

Results

Risperidone and quetiapine were the most commonly prescribed medications, but were not associated with time until dischargeable. Olanzapine (40.9 vs. 16.2 days until dischargeable, β = 0.23, p = .001), regular benzodiazepine (32.7 vs. 16.5 days until dischargeable, β = 0.15, p = .027), and as-needed (‘PRN’) benzodiazepine use (31.7 vs. 15.9 days until dischargeable, β =0.19, p = .006) were independently associated with prolonging time until dischargeable.

Conclusions

Olanzapine, benzodiazepine, and PRN benzodiazepine use were associated with longer time until patients with dementia and agitation were considered ready for discharge. This raises the question as to whether the risks of these medications outweigh the benefits in a hospital setting.

Schlagwörter

Stichwörter der Autor:innen

agitationdementiageriatric inpatient unitlength of staytime until dischargeable

Autor:innen und Institutionen

  • GeriPARTy Research Group, Dept. of Psychiatry, Lady Davis Institute/Jewish General Hospital, McGill University, Montreal, QC.
  • Division of Geriatric Medicine, Lady Davis Institute/Jewish General Hospital, McGill University, Montreal, QC.

Zitieren

APA

Silverstone-Simard, I., Wu, J., Nassim, M., Friedman, R., Segal, M., Monette, J., & Rej, S. (2021). Management of Agitation in Dementia and Effects on Inpatient Length of Stay. Canadian Geriatrics Journal, 24(2), 111-117. https://doi.org/10.5770/cgj.24.483

Vancouver

Silverstone-Simard I, Wu J, Nassim M, Friedman R, Segal M, Monette J, et al. Management of Agitation in Dementia and Effects on Inpatient Length of Stay. Canadian Geriatrics Journal. 2021;24(2):111-117. doi:10.5770/cgj.24.483

BibTeX
@article{SilverstoneSimard2021,
  author = {Silverstone-Simard, Isabelle and Wu, Joyce and Nassim, Marouane and Friedman, Ruby and Segal, Marilyn and Monette, Johanne and Rej, Soham},
  title = {Management of Agitation in Dementia and Effects on Inpatient Length of Stay},
  journal = {Canadian Geriatrics Journal},
  year = {2021},
  volume = {24},
  number = {2},
  pages = {111--117},
  doi = {10.5770/cgj.24.483}
}
Kostenlos starten →